Autoimmune Diseases  >>  ISIS-CRPRx  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ISIS-CRPRx / Ionis
NCT01414101: Safety, Tolerability, and Pharmacodynamic Study of ISIS CRP Rx in Rheumatoid Arthritis

Completed
2
51
Canada, RoW
ISIS CRP Rx or Placebo
Ionis Pharmaceuticals, Inc.
Rheumatoid Arthritis
05/13
05/13

Download Options